CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation

Cionic Neural Sleeve Now Available at Leading Medical Institutions International Multiple Sclerosis Management Practice, MedStar Health, and Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center

CIONIC, the pioneering neurotech company that created the FDA-cleared Cionic Neural Sleeve, today announced three new Centers of Excellence at renowned institutions including International Multiple Sclerosis Management Practice (IMSMP) in New York City, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center’s MS Center in Neptune, NJ, and MedStar Health with centers across Maryland, Virginia, and Washington, D.C.

CIONIC, in collaboration with qualified clinicians at the Centers of Excellence, utilizes the Neural Sleeve and proprietary neuromodulation platform to deliver a seamless care experience from the clinical environment to the home or community setting. The Neural Sleeve is the first bionic clothing that analyzes and augments human movement, enabling individuals with multiple sclerosis, stroke, spinal cord injuries, and other neurologic diagnoses to move with more freedom and control.

Individuals interested in experiencing the Neural Sleeve can contact their doctor at these Centers of Excellence to make an appointment to try the Neural Sleeve, or contact CIONIC directly at https://cionic.com/coe. The Cionic Neural Sleeve is a mobility aid that is available by prescription only.

“Digital therapeutics are set to transform healthcare, not only through continuous monitoring of patient metrics, but also by delivering real-time care personalized to individual needs. This will only happen through deep collaboration with healthcare providers,” said Jeremiah Robison, CIONIC Founder & CEO. “We are proud to work with IMSMP, Jersey Shore University Medical Center, and MedStar Health to deliver a unified care experience with the Neural Sleeve from the clinic to the home, setting a new standard for mobility care.”

“For over sixty years, IMSMP has provided individuals living with multiple sclerosis industry-leading care that prioritizes access to the latest research,” said Dr. Saud Sadiq, Medical Director of IMSMP. “Our comprehensive, holistic approach addresses the full continuum of care, which includes making the most advanced technology available to our patients and empowering them to live full and independent lives.” Together with partner organization Tisch MS Research Center of New York, their New York City-based facilities make up the largest independently-funded MS center in the world.

“The work we do at our MS Center focuses on providing care that addresses patient needs at every step of their journey with their illness, from diagnosis through treatment,” said David Duncan, M.D., medical director of the MS Center at Jersey Shore University Medical Center, a National Multiple Sclerosis Society designated Center for Comprehensive MS Care. “By integrating innovative technologies like the Neural Sleeve into patient care, we deliver on our commitment to providing the full breadth of resources available to assist our patients with living active and healthy lives.”

CIONIC Centers of Excellence are leading neurological rehabilitation centers that represent the gold standard for patient care. In strategic collaboration with these centers, patients will have an opportunity to experience the Cionic Neural Sleeve under the guidance and expertise of staff. Current Centers of Excellence include Shirley Ryan AbilityLab, the number-one ranked rehabilitation hospital in the country, according to U.S. News & World Report, UCHealth University of Colorado Hospital, the region’s largest adult academic medical center, Craig Hospital, a world-renowned rehabilitation hospital that exclusively specializes in neurorehabilitation, and Neuro Physical Therapy, a distinguished physical therapy practice.

How the Cionic Neural Sleeve Works

Backed by clinical evidence and FDA-cleared, the award-winning Cionic Neural Sleeve analyzes, predicts, and augments an individual’s movement. It uses a dense array of sensors to measure the firing patterns of individual muscles and the resultant position of the leg during movement. Algorithms running on the sleeve analyze this data in real-time to predict intended movement and determine optimal muscle activation patterns. The Cionic Neural Sleeve then delivers Functional Electrical Stimulation to sequence proper muscle firing for natural movement. It is an adaptive system that provides real-time augmentation and adjustment of the wearer’s movement, updating each time they take a step. The Cionic Neural Sleeve has been recognized in numerous global design and healthcare competitions, including TIME Best Inventions, the Digital Health Hub Awards, Fierce Life Sciences Innovation Awards, Fast Company World Changing Ideas, MedTech Innovation Awards, International Design Excellence Awards, iF DESIGN AWARD, Edison Awards, and more.

SourceCionic

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."